E D Rosenstein

Summary

Affiliation: Newark Beth Israel Medical Center
Country: USA

Publications

  1. ncbi Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis
    Elliot D Rosenstein
    Center for Rheumatic and Autoimmune Diseases, Livingston, New Jersey 07039, USA
    Inflammation 28:311-8. 2004
  2. ncbi Giant cell myocarditis: most fatal of autoimmune diseases
    E D Rosenstein
    Division of Rheumatology and Arthritis and Rheumatic Disease Center, St Barnabas Medical Center, Livingston, NJ 07039, USA
    Semin Arthritis Rheum 30:1-16. 2000
  3. ncbi Pilot study of dietary fatty acid supplementation in the treatment of adult periodontitis
    Elliot D Rosenstein
    Arthritis and Rheumatic Disease Center, St Barnabas Medical Center, 200 South Orange Avenue, Livingston, NJ 07039, USA
    Prostaglandins Leukot Essent Fatty Acids 68:213-8. 2003
  4. ncbi A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide
    I Sabnani
    Division of Hematology Oncology, Newark Beth Israel Medical Center, Newark, NJ 07112, USA
    Rheumatology (Oxford) 48:49-52. 2009
  5. ncbi Comparison of the effects of ketoprofen on platelet function in the presence and absence of aspirin
    R M Van Solingen
    Department of Medicine, Saint Barnabas Medical Center, 200 South Orange Avenue, Livingston, NJ 07039, USA
    Am J Med 111:285-9. 2001
  6. ncbi Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis
    Neil Kramer
    St. Barnabas Medical Center, Livingston, New Jersey, USA
    Arthritis Rheum 47:670-1. 2002

Collaborators

Detail Information

Publications6

  1. ncbi Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis
    Elliot D Rosenstein
    Center for Rheumatic and Autoimmune Diseases, Livingston, New Jersey 07039, USA
    Inflammation 28:311-8. 2004
    ..PAD engendered antigens lead to production of rheumatoid factor-containing immune complexes and provoke local inflammation, both in gingiva and synovium via Fc and C5a receptors...
  2. ncbi Giant cell myocarditis: most fatal of autoimmune diseases
    E D Rosenstein
    Division of Rheumatology and Arthritis and Rheumatic Disease Center, St Barnabas Medical Center, Livingston, NJ 07039, USA
    Semin Arthritis Rheum 30:1-16. 2000
    ..To increase awareness of giant cell myocarditis (GCM), its pathogenesis, and treatment...
  3. ncbi Pilot study of dietary fatty acid supplementation in the treatment of adult periodontitis
    Elliot D Rosenstein
    Arthritis and Rheumatic Disease Center, St Barnabas Medical Center, 200 South Orange Avenue, Livingston, NJ 07039, USA
    Prostaglandins Leukot Essent Fatty Acids 68:213-8. 2003
    ..Additional studies will be necessary to more fully assess the potential of these agents to favorably affect periodontal inflammation...
  4. ncbi A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide
    I Sabnani
    Division of Hematology Oncology, Newark Beth Israel Medical Center, Newark, NJ 07112, USA
    Rheumatology (Oxford) 48:49-52. 2009
    ..g. cyclophosphamide (CYC) and imatinib (PDGFR inhibitor), might be useful for treating SSc-related ILD. Our objective was to evaluate the safety and efficacy of this combination therapy in scleroderma-related pulmonary disease...
  5. ncbi Comparison of the effects of ketoprofen on platelet function in the presence and absence of aspirin
    R M Van Solingen
    Department of Medicine, Saint Barnabas Medical Center, 200 South Orange Avenue, Livingston, NJ 07039, USA
    Am J Med 111:285-9. 2001
    ..Trials are warranted to determine whether these in vitro effects result in clinical antiplatelet activity in patients who require chronic treatment with NSAIDs, thereby avoiding the toxicity of NSAID/aspirin combination therapy...
  6. ncbi Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis
    Neil Kramer
    St. Barnabas Medical Center, Livingston, New Jersey, USA
    Arthritis Rheum 47:670-1. 2002